Article in Future microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
João Paulo Salvaterra PasquiniPostgraduate Program in Bioscience & Physiopathology, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0002-8606-9150
Paula Assis QueirozPostgraduate Program in Bioscience & Physiopathology, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0002-0730-7609
Pedro Henrique Rodrigues do AmaralPostgraduate Program in Health Sciences, State University of Maringa, Parana, Brazil.ORCID 0000-0002-8596-7872
Thalita Camilo da SilvaDepartment of Clinical Analysis & Biomedicine, State University of Maringa, Maringa, Parana, Brazil.ORCID 0009-0006-1435-184X
Patricia de Souza Bonfim MendonçaDepartment of Clinical Analysis & Biomedicine, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0002-0116-2189
Fábio VandresenDepartment of Chemistry, Federal Technological University of Parana, Londrina, Parana, Brazil.ORCID 0000-0002-6851-1734
João Pedro Carvalho CeolisDepartment of Chemistry, Federal Technological University of Parana, Londrina, Parana, Brazil.
Regiane Bertin de Lima ScodroPostgraduate Program in Health Sciences, State University of Maringa, Parana, Brazil.ORCID 0000-0002-9129-2445
Katiany Rizzieri Caleffi-FerracioliPostgraduate Program in Bioscience & Physiopathology, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0003-0345-1600
Rosilene Fressatti CardosoPostgraduate Program in Bioscience & Physiopathology, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0001-6228-4780
Vera Lúcia Dias SiqueiraPostgraduate Program in Bioscience & Physiopathology, State University of Maringa, Maringa, Parana, Brazil.ORCID 0000-0001-7973-4098
Funding
Brazilian National Council for Scientific and Technological Development - CNPq MCTIC/CNPq No 28/2018 - UNIVERSAL/A
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Polymyxin B adjuvants against polymyxin B- and carbapenem-resistant Gram-negative bacteria. · full record | OpenQuestion